Squarepoint’s CureVac CVAC Stock Holding History

Squarepoint’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-22,141	Closed	-$119K	–	4370
2025 Q3	$119K	Buy	+22,141	New	+$120K	﹤0.01%	4076
2025 Q2	–	Sell	-65,960	Closed	-$183K	–	4585
2025 Q1	$183K	Buy	65,960 +49,917	+311%	+$174K	﹤0.01%	4046
2024 Q4	$54.7K	Sell	16,043 -23,122	-59%	-$66.7K	﹤0.01%	4829
2024 Q3	$115K	Buy	+39,165	New	+$129K	﹤0.01%	3842
2024 Q2	–	Sell	-10,414	Closed	-$31.6K	–	4160
2024 Q1	$31.6K	Buy	+10,414	New	+$36.6K	﹤0.01%	3902
2022 Q4	–	Sell	-27,387	Closed	-$216K	–	3239
2022 Q3	$216K	Sell	27,387 -35,906	-57%	-$419K	﹤0.01%	2653
2022 Q2	$861K	Buy	+63,293	New	+$1.05M	﹤0.01%	1702
2021 Q4	–	Sell	-6,800	Closed	-$371K	–	3215
2021 Q3	$371K	Sell	6,800 -2,420	-26%	-$146K	﹤0.01%	2144
2021 Q2	$677K	Buy	9,220 +2,377	+35%	+$238K	﹤0.01%	1926
2021 Q1	$626K	Buy	+6,843	New	+$664K	﹤0.01%	1852

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Squarepoint's CVAC Position: Q4 2025 in Review

Squarepoint sold out of CureVac (CVAC) in Q4 2025, closing a stake of 22,141 shares — an estimated $119K sold.

Squarepoint first reported a position in CVAC in Q1 2021 and held it in 10 quarters. The position peaked at $861K in Q2 2022. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Squarepoint reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Squarepoint sold 22,141 CureVac shares in Q4 2025, an estimated $119K.
Squarepoint first reported a position in CureVac in Q1 2021 and held it in 10 quarters.
Squarepoint's CureVac position peaked at $861K in Q2 2022.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.